Inducing a cascade of signaling molecules, i.e., pro-tumorigenic cytokines interleukin-6 (IL-6), IL-8 and tumor necrosis factor-α (TNF-α), induces the NF-κB transcriptional survival program, protecting tumor cells against cell death. This evidence concerns the gene NFKB1 and neoplasm.